Natural products and hepatocellular carcinoma: a review

Asma M. Alnajjar , Hussien A. Elsiesy

Hepatoma Research ›› 2015, Vol. 1 : 119 -24.

PDF
Hepatoma Research ›› 2015, Vol. 1:119 -24. DOI: 10.4103/2394-5079.167379
Review
Review

Natural products and hepatocellular carcinoma: a review

Author information +
History +
PDF

Abstract

Hepatocellular carcinoma (HCC) is the fifth commonest cause of malignancy and the third cause of cancer mortality. There are different treatment options for HCC ranging from loco-regional therapy to surgical treatment. Different regimen of systemic chemotherapy has been tried with a poor response. Several studies aimed at discovering more molecules for the management of HCC. Those studies aimed at recognizing and targeting several signalling and molecular pathways that lead to cellular proliferation and tumour formation. In this review, we discussed the role of several agents found in natural and dietary products such as curcumin, resveratrol, flavonoids, Rubus aleaefolious Poir total alkaloids, Livistona chinesis seed, and crocetin. We had used the names of the above-mentioned products as key words in addition to “Hepatocellular Carcinoma” on PubMed to find studies that discussed their roles in HCC. Articles were downloaded for reviewing and discussing natural products that had adequate studies in treating HCC.

Keywords

Hepatocellular carcinoma / molecular signaling / natural products

Cite this article

Download citation ▾
Asma M. Alnajjar, Hussien A. Elsiesy. Natural products and hepatocellular carcinoma: a review. Hepatoma Research, 2015, 1: 119-24 DOI:10.4103/2394-5079.167379

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Schutte K,Malfertheiner P.Hepatocellular carcinoma-epidemiological trends and risk factors..Dig Dis2009;27:80-92

[2]

Thun MJ,Center MM,Ward EM.The global burden of cancer: priorities for prevention..Carcinogenesis2010;31:100-10 PMCID:PMC2802672

[3]

Sokolowski KM,Kunnimalaiyaan S,Kunnimalaiyaan M.Notch signaling in hepatocellular carcinoma: molecular targeting in an advanced disease..Hepatoma Res2015;1:11-8

[4]

Sherman M.Hepatocellular carcinoma: epidemiology, risk factors, and screening..Semin Liver Dis2005;25:143-54

[5]

Siegel R,Jemal A.Cancer statistics, 2012..CA Cancer J Clin2012;62:10-29

[6]

Jemal A,Center MM,Ward E.Global cancer statistics..CA Cancer J Clin2011;61:69-90

[7]

Chen J.Trends in the incidence of liver cancer and its primary prevention in China..Chin J Clin Hepatol2012;4:256-60

[8]

Bartsch H.Relevance of nitrosamines to human cancer..Carcinogenesis1984;5:1381-93

[9]

Okuda K.Hepatocellular carcinoma..J Hepatol2000;32:225-37

[10]

Bruix J.Hepatis B virus and hepatocellular carcinoma..J Hepatol2003;39:S59-63

[11]

Kensler TW,Wang JB,Zhang BC,Chen JG,Kuang SY,Gange SJ,Mu-oz A.Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas..Gastroenterology2004;127:S310-8

[12]

Darvesh AS.Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer..Nutr Cancer2013;65:329-44

[13]

Ha HL,Feitelson MA.Oxidative stress and antioxidants in hepatic pathogenesis..World J Gastroenterol2010;16:6035-43 PMCID:PMC3012582

[14]

Klaunig JE.The role of oxidative stress in carcinogenesis..Annu Rev Pharmacol Toxicol2004;44:239-67

[15]

Pang R,Poon RT.Molecular pathways in hepatocellular carcinoma..Cancer Lett2006;240:157-69

[16]

Wong CM.Molecular pathogenesis of hepatocellular carcinoma..Liver Int2008;28:160-74

[17]

Frau M,Feo F.Prognostic markers and putative therapeutic targets for hepatocellular carcinoma..Mol Aspects Med2010;31:179-93

[18]

Darvesh AS,Bishayee A.Curcumin and liver cancer: a review..Curr Pharm Biotechnol2012;13:218-28

[19]

Lee JH,Kim YJ,Chung JW.Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area..J Gastroenterol Hepatol2015;30:696-705

[20]

Takayasu K,Moriyama N,Makuuchi M,Hirohashi S.Clinical and radiologic assessments of the results of hepatectomy for small hepatocellular carcinoma and therapeutic arterial embolization for postoperative recurrence..Cancer1989;64:1848-52

[21]

Sato M,Ueda S,Abe Y,Kimura S,Onji M.Microwave coagulation therapy for hepatocellular carcinoma..Gastroenterology1996;110:1507-14

[22]

Llovet JM,Bruix J.Hepatocellular carcinoma..Lancet2003;362:1907-17

[23]

Mazzaferro V,Doci R,Pulvirenti A,Montalto F,Morabito A.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis..N Engl J Med1996;334:693-9

[24]

Llovet JM,Mazzaferro V,Gane E,de Oliveira AC,Raoul JL,Schwartz M,Zeuzem S,Greten TF,Seitz JF,Häussinger D,Shan M,Voliotis D.Sorafenib in advanced hepatocellular carcinoma..N Engl J Med2008;359:378-90

[25]

Je Y,Choueiri TK.Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials..Lancet Oncol2009;10:967-74

[26]

Lu SC.Where are we in the chemoprevention of hepatocellular carcinoma?.Hepatology2010;51:734-6

[27]

Dai XZ,Sun LF,Zhou C,Zhang W,Li XC.Potential therapeutic efficacy of curcumin in liver cancer..Asian Pac J Cancer Prev2013;14:3855-9

[28]

Lin W,Cao Z,Zheng L,Chen D,Hong Z.Livistona chinensis seed suppresses hepatocellular carcinoma growth through promotion of mitochondrial-dependent apoptosis..Oncol Rep2013;29:1859-66

[29]

Xia JF,Inagaki Y,Nakata M.Flavonoids as potential anti-hepatocellular carcinoma agents: recent approaches using HepG2 cell line..Drug Discov Ther2013;7:1-8

[30]

Aggarwal BB.Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases..Int J Biochem Cell Biol2009;41:40-59 PMCID:PMC2637808

[31]

Sugiyama Y,Osawa T.Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin..Biochem Pharmacol1996;52:519-25

[32]

Singh S.Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]..J Biol Chem1995;270:24995-5000

[33]

Libby P.Inflammatory mechanisms: the molecular basis of inflammation and disease..Nutr Rev2007;65:S140-6

[34]

Ralhan R,Aggarwal BB.Nuclear factor-kappa B links carcinogenic and chemopreventive agents..Front Biosci (Schol Ed)2009;1:45-60

[35]

Shishodia S,Lai R.Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma..Biochem Pharmacol2005;70:700-13

[36]

Kamat AM,Aggarwal BB.Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells..Mol Cancer Ther2007;6:1022-30

[37]

Li L,Shishodia S,Kurzrock R.Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis..Cancer2004;101:2351-62

[38]

Shakibaei M,John T.Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: an immunomorphological study..Ann Anat2005;187:487-97

[39]

Skommer J,Pelkonen J.Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4..Exp Hematol2007;35:84-95

[40]

Wang S,Shi W,Yu X,Zhang J.Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling..IUBMB Life2011;63:775-82

[41]

Lin LI,Ko YC.Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion..Oncology1998;55:349-53

[42]

Chiablaem K,Keeratichamroen S,Svasti J.Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition..Anticancer Res2014;34:1857-64

[43]

Shoji M,Watanabe A,Yamada T,Kimura F.Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells..Food Chem2014;151:126-32

[44]

Bandyopadhyay D.Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer..Front Chem2014;2:113 PMCID:PMC4275038

[45]

Bishayee A,Darvesh AS.Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma..Cancer Treat Rev2010;36:43-53

[46]

Baur JA.Therapeutic potential of resveratrol: the in vivo evidence..Nat Rev Drug Discov2006;5:493-506

[47]

Udenigwe CC,Aluko RE.Potential of resveratrol in anticancer and anti-inflammatory therapy..Nutr Rev2008;66:445-54

[48]

Saiko P,Jaeger W.Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?.Mutat Res2008;658:68-94

[49]

Shankar S,Srivastava RK.Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential..Front Biosci2007;12:4839-54

[50]

Das S.Anti-inflammatory responses of resveratrol..Inflamm Allergy Drug Targets2007;6:168-73

[51]

Rubiolo JA,Vega FV.Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes..Eur J Pharmacol2008;591:66-72

[52]

Delmas D,Cherkaoui Malki M.Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines..Oncol Rep2000;7:847-52

[53]

Kuo PL,Lin CC.Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells..Life Sci2002;72:23-34

[54]

De Ledinghen V,Neaud V,Payrastre B,Desmoulière A,Rosenbaum J.Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells..Int J Oncol2001;19:83-8

[55]

Zhang Q,Lu QY,Brown J.Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells..Mol Cancer Ther2005;4:1465-74

[56]

Kocsis Z,Jakab MG,Tompa A.Chemopreventive properties of trans-resveratrol against the cytotoxicity of chloroacetanilide herbicides in vitro..Int J Hyg Environ Health2005;208:211-8

[57]

Sun Z,Liu H.Anti-hepatoma activity of resveratrol in vitro..World J Gastroenterol2002;8:79-81 PMCID:PMC4656631

[58]

Notas G,Kampa M,Kouroumalis E.Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation..Biochim Biophys Acta2006;1760:1657-66

[59]

Yu H,Zhao S,Zhang H.Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells..Biomed Pharmacother2008;62:366-72

[60]

Yerian LM,Tretiakova M.Caveolin and thrombospondin expression during hepatocellular carcinogenesis..Am J Surg Pathol2004;28:357-64

[61]

Yu L,Wu SL.Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer..World J Gastroenterol2003;9:2341-3 PMCID:PMC4656492

[62]

Nijveldt RJ,van Hoorn DE,van Norren K.Flavonoids: a review of probable mechanisms of action and potential applications..Am J Clin Nutr2001;74:418-25

[63]

Ververidis F,Douglas C,Kretzschmar G.Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health..Biotechnol J2007;2:1214-34

[64]

Cui X,Kokudo N,Tang W.Traditional Chinese medicine and related active compounds against hepatitis B virus infection..Biosci Trends2010;4:39-47

[65]

Handoussa H,Ayoub N.Spicatic acid: A 4-carboxygentisic acid from Gentiana spicata extract with potential hepatoprotective activity..Drug Discov Ther2009;3:278-86

[66]

Abdel-Salam OM,Mohammed NA,Omara E.Neuroprotective and hepatoprotective effects of micronized purified flavonoid fraction (Daflon(R)) in lipopolysaccharide-treated rats..Drug Discov Ther2012;6:306-14

[67]

Jiang CP,Shi DH,Li EG.Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells..World J Gastroenterol2012;18:1753-64 PMCID:PMC3332288

[68]

Dorn C,Motyl M,Gehrig M,Heilmann J.Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis..Mol Nutr Food Res2010;54:S205-13

[69]

Jin J,Wei W,Hu SS,Wu YJ.Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro..Acta Pharmacol Sin2012;33:701-9 PMCID:PMC4010354

[70]

Sharma A,Bhat MK.Inhibition of Hsp27 and Hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells..Cancer Biol Ther2009;8:2106-13

[71]

He W,Liao QJ,Chen XL.Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line..World J Gastroenterol2011;17:1507-14 PMCID:PMC3070027

[72]

Lee JC,Wu SF,Chiu CC.San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression..J Viral Hepat2011;18:e315-24

[73]

Zhao J,Lin W,Zhuang Q,Hong Z.Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis..Int J Oncol2013;42:971-8

[74]

Hong Z,Zhao J,Zhou J,Hu J.Hepatoprotective effects of Rubus aleaefolius Poir. and identification of its active constituents..J Ethnopharmacol2010;129:267-72

[75]

Xue H,Sun N,Kamendulis LM,Stoner GD.Inhibition of cellular transformation by berry extracts..Carcinogenesis2001;22:351-6

[76]

Lee JH,Choi SH,Jung JH,Kim DK,Wang MW.Activity of crude extract of Rubus crataegifolius roots as a potent apoptosis inducer and DNA topoisomerase I inhibitor..Arch Pharm Res2000;23:338-43

[77]

Borner C.The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions..Mol Immunol2003;39:615-47

[78]

Ow YP,Hao Z.Cytochrome c: functions beyond respiration..Nat Rev Mol Cell Biol2008;9:532-42

[79]

Zhao G,Chen R.Dictionary of traditional Chinese medicine.2006;ShanghaiShanghai Scientific and Technical Publishers2459-60

[80]

Bolhassani A,Bathaie SZ.Saffron and natural carotenoids: Biochemical activities and anti-tumor effects..Biochim Biophys Acta2014;1845:20-30

[81]

Bakshi H,Rozati R,Islam T,Lone Z,Triphati J.DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by crocin from kashmiri saffron in a human pancreatic cancer cell line..Asian Pac J Cancer Prev2010;11:675-9

[82]

Bathaie SZ,Mohagheghi MA,Shahbazfar AA.Saffron Aqueous Extract Inhibits the Chemically-induced Gastric Cancer Progression in the Wistar Albino Rat..Iran J Basic Med Sci2013;16:27-38 PMCID:PMC3637902

[83]

Sun Y,Zhao YX,Sun LR,Sun XF.Crocin exhibits antitumor effects on human leukemia HL-60 cells in vitro and in vivo..Evid Based Complement Alternat Med2013;2013:690164

[84]

Noureini SK.Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation..Asian Pac J Cancer Prev2012;13:2305-9

[85]

Li CY,Wang QL,Cai E,Du JC,Chen R,Feng J.Crocetin induces cytotoxicity in colon cancer cells via p53-independent mechanisms..Asian Pac J Cancer Prev2012;13:3757-61

[86]

Tseng TH,Huang JM,Wang CJ.Crocetin protects against oxidative damage in rat primary hepatocytes..Cancer Lett1995;97:61-7

PDF

69

Accesses

0

Citation

Detail

Sections
Recommended

/